Ancilia Biosciences
Business Services · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
4518 Court Sq, Long Island City, New Yor...Website
www.anciliabio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Ancilia Biosciences
Ancilia Bio is a biotechnology company developing CRISPR-enabled bacterial therapies and microbial products designed to resist destructive viruses. Its platforms focus on virome analysis and enhancing bacterial immunity for therapeutic and industrial applicationsExplore more
Ancilia Biosciences Org Chart
Get the full picture
Sign in to uncover key details.
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Ancilia Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Ancilia Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Ancilia Biosciences had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Ancilia Biosciences
Check if Ancilia Biosciences has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Ancilia Biosciences recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Ancilia Biosciences is spiking on competitors!
Funding: Get notified immidiatlly once Ancilia Biosciences has new funding data
Product Launch: Get notified when Ancilia Biosciences launches new products
Recommended Actions
Find VP level buyers at Ancilia Biosciences
Find 2 more new buyers
Compare Similar Companies to Ancilia Biosciences
Compare insights from companies similar to Ancilia Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Ancilia Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Ancilia Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Ancilia Biosciences.
Ancilia Biosciences financials insights
Gather financial insights about Ancilia Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Other Financing Round
$4.2M
2026
Stock/Share Issuance
$10.1M
Ancilia Biosciences Tech Stack
A closer look at the technologies used by Ancilia Biosciences
See more technologies
Most Recent Scoops
Funding
Funding
Event
Product Marketing, Events, Sales, Logistics / Supply Chain, Field Marketing, Healthcare Operations, Healthcare Technology, Medical Administration, Operations
Person-Based
Funding
Funding
Ancilia Biosciences News & Media
Ancilia Biosciences Announces Closing of $4.2 Million Financing
Ancilia raised $4.2M to leverage CRISPR’s natural function to create bacterial therapies with immunity against the viruses that limit their effectiveness.
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding Ancilia Biosciences
Sign Up For FreeTo access detailed company insights
Ancilia Bio is a biotechnology company developing CRISPR-enabled bacterial therapies and microbial products designed to resist destructive viruses. Its platforms focus on virome analysis and enhancing bacterial immunity for therapeutic and industrial applications... Read More
